Ignota Labs
Ignota Labs is an AI-driven drug turnaround company that rescues promising but failing drugs by addressing safety issues that cause clinical trial failures. Their proprietary AI model, SAFEPATH, uses deep learning, bioinformatics, and cheminformatics to identify toxicity mechanisms and predict their effects, enabling the re-engineering and revival of therapies. The company aims to accelerate the delivery of life-saving treatments to patients by building a robust pipeline of matured assets from historically failed or abandoned projects, focusing on drugs that failed in preclinical, Phase 1, or Phase 2 trials. They have secured $6.9 million in seed funding to expand their pipeline and advance assets into early-stage clinical trials.
Ignota Labs
Ignota Labs is an AI-driven drug turnaround company that rescues promising but failing drugs by addressing safety issues that cause clinical trial failures. Their proprietary AI model, SAFEPATH, uses deep learning, bioinformatics, and cheminformatics to identify toxicity mechanisms and predict their effects, enabling the re-engineering and revival of therapies. The company aims to accelerate the delivery of life-saving treatments to patients by building a robust pipeline of matured assets from historically failed or abandoned projects, focusing on drugs that failed in preclinical, Phase 1, or Phase 2 trials. They have secured $6.9 million in seed funding to expand their pipeline and advance assets into early-stage clinical trials.